Page last updated: 2024-10-31

mitotane and Pituitary Diseases

mitotane has been researched along with Pituitary Diseases in 3 studies

Mitotane: A derivative of the insecticide DICHLORODIPHENYLDICHLOROETHANE that specifically inhibits cells of the adrenal cortex and their production of hormones. It is used to treat adrenocortical tumors and causes CNS damage, but no bone marrow depression.

Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Randolph, JF1
Toomey, J1
Center, SA1
Scarlett, JM1
Reimers, T1
Graham, P1
Nachreiner, RF1
Bennett, PF1
Norman, EJ1
Peterson, ME1

Reviews

1 review available for mitotane and Pituitary Diseases

ArticleYear
Medical treatment of canine pituitary-dependent hyperadrenocorticism (Cushing's disease).
    The Veterinary clinics of North America. Small animal practice, 2001, Volume: 31, Issue:5

    Topics: Animals; Antifungal Agents; Cushing Syndrome; Dog Diseases; Dogs; Dose-Response Relationship, Drug;

2001

Other Studies

2 other studies available for mitotane and Pituitary Diseases

ArticleYear
Use of the urine cortisol-to-creatinine ratio for monitoring dogs with pituitary-dependent hyperadrenocorticism during induction treatment with mitotane (o,p'-DDD).
    American journal of veterinary research, 1998, Volume: 59, Issue:3

    Topics: Adrenocortical Hyperfunction; Adrenocorticotropic Hormone; Animals; Antineoplastic Agents, Hormonal;

1998
Mitotane (o,p'-DDD) resistance in a dog with pituitary-dependent hyperadrenocorticism and phaeochromocytoma.
    Australian veterinary journal, 1998, Volume: 76, Issue:2

    Topics: Adrenal Cortex Function Tests; Adrenal Gland Neoplasms; Adrenal Medulla; Adrenocortical Hyperfunctio

1998